Expression of costimulatory molecules B7/CD28 in systemic lupus erythematosus

Abstract

The expression of the constimulatory molecules B7/CD28 in peripheral blood mononuclear cells (PBMC) of the patients with systemic lupus erythematosus (SLE) and its relation to the pathogenesis of SLE were studied. The expression of the costimulatory molecules in PBMC in 30 patients with active SLE and 20 cases of healthy controls was detected by using the techniques of immunofluorescence and flow cytometer. The result showed that the expression percentage of CD28', CD4' CD28 in T cells of PBMC from the patients with SLE decreased significantly as compared with that in healthy control group, while the expression percentage of CD80⁺, CD19⁺ CD80⁺ in B cells was significantly increased than that in healthy control group (P<0.01). It suggested that the abnormal expression of costimulatory molecules B7/CD28 played a role in the pathogenesis of SLE.

Keywords

systemic lupus erythematosus / costimulatory molecules / flow cytometer

References

[1] HochbergM C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1997, 40(9): 1725-1725

[2] ChambersC A, AllisonJ P. Co-stimulation in T cell responses. Curr Opin Immunol, 1997, 9(3): 396-396

[3] MamulaM J. Epitope spreading: the role of self peptides and autoantigen processing by B lymphocytes. Immunol Rev., 1998, 164231-231

[4] McAdamA J, SchweitzerA N, SharpeA H. The role of B7 co-stimulation in activation and differentiation of CD4⁺ and CD8⁺ T cells. Immunol Rev, 1998, 165231-231

[5] JudgeT A, TangA, TurkaL A. Imunosuppression through blockade of CD28: B7 mediate costmulatory signals. Immunol Res, 1996, 15(1): 38-38

[6] HorwitzD A, TangF L, StimmlerM M, et al. . Decreased T cell response to anti-CD2 in systemic lupus erythematosus and reversal by anti-CD28: evidence for impaired T cell-accessory cell interaction. Arthritis Rheum, 1997, 40(5): 822-822

[7] KanekoH, SaitoK, HashimotoH, et al. . Preferential elimination of CD28⁺ T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis. Clin Exp Immunol, 1996, 106(2): 218-218

[8] FolzenlogenD, HoferM F, LeungD Y, et al. . Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. Clin Immunopathol, 1997, 83(3): 199-199

[9] ChambersB J, SalcedoM, LjunggrenH G. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity, 1996, 5(4): 311-311